<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2021.634382</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>CryptoType &#x2013; Public Datasets for MALDI-TOF-MS Based Differentiation of <italic>Cryptococcus neoformans/gattii</italic> Complexes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bernhard</surname>
<given-names>Mareike</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Worasilchai</surname>
<given-names>Navaporn</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kangogo</surname>
<given-names>Mourine</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bii</surname>
<given-names>Christine</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Trzaska</surname>
<given-names>Wioleta J.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weig</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gro&#xdf;</surname>
<given-names>Uwe</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/452596"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chindamporn</surname>
<given-names>Ariya</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Bader</surname>
<given-names>Oliver</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/864335"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Institute for Medical Microbiology, University Medical Center G&#xf6;ttingen</institution>, <addr-line>G&#xf6;ttingen</addr-line>, <country>Germany</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Microbiology, Faculty of Medicine, Chulalongkorn University</institution>, <addr-line>Bangkok</addr-line>, <country>Thailand</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Medical Microbiology, Jomo Kenyatta University of Agriculture and Technology</institution>, <addr-line>Nairobi</addr-line>, <country>Kenya</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Center for Microbiology Research, Mycology Laboratory, Kenya Medical Research Institute</institution>, <addr-line>Nairobi</addr-line>, <country>Kenya</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>School of Biosciences, Institute of Microbiology and Infection, University of Birmingham</institution>, <addr-line>Birmingham</addr-line>, <country>United Kingdom</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Di Xiao, National Institute for Communicable Disease Control and Prevention (China CDC), China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Bryan Schmitt, Indiana University Bloomington, United States; Volker Rickerts, Robert Koch Institute (RKI), Germany</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Oliver Bader, <email xlink:href="mailto:oliver.bader@med.uni-goettingen.de">oliver.bader@med.uni-goettingen.de</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Clinical Microbiology, a section of the journal Frontiers in Cellular and Infection Microbiology</p>
</fn>
<fn fn-type="present-address" id="fn003">
<p>&#x2020;Present address: Navaporn Worasilchai, Department of Transfusion Medicine and Clinical Microbiology, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>04</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>11</volume>
<elocation-id>634382</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>11</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>03</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Bernhard, Worasilchai, Kangogo, Bii, Trzaska, Weig, Gro&#xdf;, Chindamporn and Bader</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Bernhard, Worasilchai, Kangogo, Bii, Trzaska, Weig, Gro&#xdf;, Chindamporn and Bader</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Yeasts of the <italic>Cryptococcus neoformans</italic>/<italic>gattii</italic> species complexes are human pathogens mostly in immune compromised individuals, and can cause infections from dermal lesions to fungal meningitis. Differences in virulence and antifungal drug susceptibility of species in these complexes indicate the value of full differentiation to species level in diagnostic procedures. MALDI-TOF MS has been reported to sufficiently discriminate these species. Here, we sought to re-evaluate sample pre-processing procedures and create a set of publicly available references for use with the MALDI Biotyper system. Peak content using four different pre-processing protocols was assessed, and database entries for 13 reference strains created. These were evaluated against a collection of 153 clinical isolates, typed by conventional means. The use of decapsulating protocols or mechanical disruption did not sufficiently increase the information content to justify the extra hands-on-time. Using the set of 13 reference entries created with the standard formic acid extraction, we were able to correctly classify 143/153 (93.5%) of our test isolates. The majority of the remaining ten isolates still gave correct top matches; only two isolates did not give reproducible identifications. This indicates that the log score cut-off can be lowered also in this context. Ease to identify cryptococcal isolates to the species level is improved by the workflow evaluated here. The database references are freely available from <uri xlink:href="https://github.com/oliverbader/BioTyper-libraries">https://github.com/oliverbader/BioTyper-libraries</uri> for incorporation into local diagnostic systems.</p>
</abstract>
<kwd-group>
<kwd>MALDI-TOF MS</kwd>
<kwd>identification</kwd>
<kwd>capsule</kwd>
<kwd>
<italic>Cryptococcus neoformans</italic> complex</kwd>
<kwd>
<italic>Cryptococcus gattii</italic> complex</kwd>
</kwd-group>
<contract-sponsor id="cn001">Bundesministerium f&#xfc;r Bildung und Forschung<named-content content-type="fundref-id">10.13039/501100002347</named-content>
</contract-sponsor>
<counts>
<fig-count count="3"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="26"/>
<page-count count="6"/>
<word-count count="2550"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>The group of basidiomycetous yeast of the <italic>Cryptococcus neoformans/gattii</italic> complexes hosts a variety of human pathogenic species, causing infections from skin lesions to fatal meningitis [reviewed in (<xref ref-type="bibr" rid="B14">Kronstad et&#xa0;al., 2011</xref>)]. This mainly contributes to morbidity and mortality in patients with underlying immune deficiencies (e.g. HIV), but can also affect immunocompetent hosts. Species of the <italic>C. neoformans/gattii</italic> complexes are readily found in the environment, living, for example, on eucalyptus tree bark, and bird droppings.</p>
<p>The most prominent diagnostic feature of these species are the large capsules of most isolates [reviewed in (<xref ref-type="bibr" rid="B19">O&#x2019;Meara and Alspaugh, 2012</xref>)], which can easily be visualized by, e.g., displacement of India ink stain. India ink does not penetrate the capsule and thus creates a halo around the cells visible in microscopy. The polysaccharides shed from the cell also give rise to efficient and specific serologic tests of cryptococcal infections through serum detection of galactomannan.</p>
<p>Species in this complex have traditionally been divided into four serotypes based on antigenicity of the capsule, forming three varieties: <italic>C. neoformans</italic> var. <italic>grubii</italic> (serotype A), var. <italic>gattii</italic> (serotypes B and C), and var. <italic>neoformans</italic> (serotype D). They are also able to form inter-species hybrids leading to, e.g., an AD serotype (<xref ref-type="bibr" rid="B2">Boekhout et&#xa0;al., 2001</xref>). Several genetic methods are available to stratify the different serotypes into further molecular types (<xref ref-type="bibr" rid="B18">Meyer et&#xa0;al., 2003</xref>) and characterize hybrid strains. Recently, it has been proposed to formally raise the non-hybrid molecular types to species level (<xref ref-type="bibr" rid="B15">Kwon-Chung et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B8">Hagen et&#xa0;al., 2015</xref>) and a fifth <italic>C. gattii</italic> lineage has recently been described (<xref ref-type="bibr" rid="B6">Farrer et&#xa0;al., 2019</xref>) from environmental and animal specimen.</p>
<p>In clinical samples from Europe most frequently serotype A is found, mainly from immunocompromised patients, e.g. those suffering from AIDS (<xref ref-type="bibr" rid="B14">Kronstad et&#xa0;al., 2011</xref>). Highly virulent isolates usually stem from the <italic>C. gattii</italic> complex, which also readily infect immuno-competent hosts. Differences in mean antifungal susceptibility between closely related molecular types have been reported (<xref ref-type="bibr" rid="B24">Trilles et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B4">Cogliati et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B16">Lee et&#xa0;al., 2019</xref>) and <italic>in vitro</italic> differences in cytokine responses (<xref ref-type="bibr" rid="B9">Herkert et&#xa0;al., 2018</xref>). Some molecular types, mainly VGII and VGIII, are more prone to be involved in outbreak scenarios (<xref ref-type="bibr" rid="B12">Kidd et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B3">Carriconde et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B21">Springer et&#xa0;al., 2014</xref>). A major difference between <italic>C. neoformans</italic> and <italic>C. gattii</italic> groups is the lack of growth inside macrophages among <italic>C. gattii</italic> isolates, with the notable exception of such outbreak lineages (<xref ref-type="bibr" rid="B25">Voelz et&#xa0;al., 2014</xref>).</p>
<p>Together this underlines the benefit of methods easily discriminating between the major molecular types, not only in clinical contexts, but also for epidemiological studies which so far rely on laborious genetic typing [e.g. our own work (<xref ref-type="bibr" rid="B22">Tangwattanachuleeporn et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B11">Kangogo et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B26">Worasilchai et&#xa0;al., 2017</xref>) or others (<xref ref-type="bibr" rid="B5">Fang et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B10">Jin et&#xa0;al., 2020</xref>)]. MALDI-TOF MS has been established over the past years as a widely used clinical species identification tool and has been shown to be able to discriminate between the seven known molecular types within the <italic>C. neoformans/gattii</italic> complexes (<xref ref-type="bibr" rid="B17">McTaggart et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B7">Firacative et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B20">Posteraro et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B8">Hagen et&#xa0;al., 2015</xref>). For <italic>C. gatti</italic> and <italic>C. deuterogatii</italic> differential mass peaks have been described (<xref ref-type="bibr" rid="B10">Jin et&#xa0;al., 2020</xref>).</p>
<p>However, this has not been implemented in diagnostic systems, which remain at the point where only <italic>C. neoformans</italic> var. <italic>neoformans/grubii</italic> vs. <italic>C. gattii</italic> complexes can be identified. In part, this may be due to the observation that false species designations above the significance threshold can be observed (<xref ref-type="bibr" rid="B20">Posteraro et&#xa0;al., 2012</xref>), and reflect the complexity introduced by hybrid formation between the different linages.</p>
<p>In this study, we created a publicly available MALDI Biotyper database reference (&#x201c;main spectrum projections&#x201d;, MSPs) set from 13 type strains of seven recognized non-hybrid subtypes in the <italic>Cryptococcus neoformans</italic>/<italic>gattii</italic> complexes. Their performance using different preprocessing protocols is evaluated on a set of characterized isolates.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2_1">
<title>Yeast Strains and Culture Conditions, Chemicals</title>
<p>For long-term storage, <italic>Cryptococcus</italic> isolates were kept at -70&#xb0;C in cryobank stocks (Mast Diagnostica, Reinfeld, Germany). After thawing, strains were propagated on Sabouraud&#x2019;s (SAB) agar slants supplemented with 0.5% peptone (casein), 0.5% peptone (meat), and 2% glucose. Before sample preparation, strains were cultivated on SAB agar overnight at 30&#xb0;C.</p>
<p>For the purpose of text clarity, only the species nomenclature according to Hagen et&#xa0;al. (<xref ref-type="bibr" rid="B8">Hagen et&#xa0;al., 2015</xref>) is adopted from here. As references, thirteen strains of the CBS collection (Westerdijk Fungal Biodiversity Institute) were used: three <italic>C. neoformans</italic> (CBS 8710 (molecular type VNI), CBS 10084 (VNII), CBS 10085(VNI)), two <italic>C. deneoformans</italic> (CBS 6900 and CBS 10079 (VNIV)), two <italic>C.&#xa0;gattii</italic> (CBS 6289,and CBS 10078, VGI), two <italic>C. deuterogattii</italic> (CBS 10082, and CBS 10514, VGII) two <italic>C. bacillisporus</italic> (CBS 6955 and CBS 10081, VGIII), one <italic>C. tetragattii</italic> (CBS 10101, VGIV), and <italic>C.&#xa0;decagattii</italic> (CBS 11687, VGIV).</p>
<p>A test set of 153 isolates was assembled from previously characterized collections. This included all Thai strains from <xref ref-type="bibr" rid="B26">Worasilchai et&#xa0;al. (2017)</xref>, augmented with rare species isolates from Kenya (<xref ref-type="bibr" rid="B11">Kangogo et&#xa0;al., 2015</xref>) and the Birmingham laboratory collection, which include strain from various studies [e.g. (<xref ref-type="bibr" rid="B25">Voelz et&#xa0;al., 2014</xref>)]. All isolates were typed either previously (<xref ref-type="bibr" rid="B11">Kangogo et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B26">Worasilchai et&#xa0;al., 2017</xref>) or specifically for the purpose of this study using the <italic>URA5</italic>-RFLP method. The final set contained n=96 <italic>C. neoformans</italic>, n=6 <italic>C. deneoformans</italic>, n=5 <italic>C. gattii</italic>, n=18 <italic>C. bacillisporus</italic>, n=20 <italic>C. deuterogattii</italic>, and n=8 <italic>C. tetragattii</italic> isolates. A negative control group was assembled from mass spectra randomly chosen from those obtained during bacterial (n=86) of fungal (n=403) routine diagnostics.</p>
</sec>
<sec id="s2_2">
<title>
<italic>URA5</italic>-RFLP</title>
<p>Restriction fragment length polymorphisms were performed as described previously (<xref ref-type="bibr" rid="B11">Kangogo et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B26">Worasilchai et&#xa0;al., 2017</xref>). Briefly, genomic DNA was extracted from cells using phenol/chloroform and the <italic>URA5</italic> gene was amplified using URA5 forward (5-ATGTCCTCCCAAGCCCTCGACTCCG-3) and SJ01 reverse (5-TTAAGACCTCTGAACACCGTACTC-3) primers (<xref ref-type="bibr" rid="B18">Meyer et&#xa0;al., 2003</xref>). The amplicons obtained were either simultaneously digested with HhaI (20 U/&#x3bc;l) and Sau96I (10 U/&#x3bc;l) or StuI (10 U/&#xb5;l) alone for 8 hours (all from New England Biolabs). The digestion products were purified using a PCR clean-up kit (NucleoSpin, Macherey-Nagel, D&#xfc;ren, Germany) and visualized on a 3% agarose gel.</p>
</sec>
<sec id="s2_3">
<title>MALDI-TOF MS Preprocessing Protocols</title>
<p>For regular harvest and formic acid-extraction [preprocessing protocol (A) (<xref ref-type="bibr" rid="B1">Bader, 2017</xref>)], cells were taken from agar plates by scraping approximately a 1&#xb5;l loop full of cells and re-suspending them in 300 &#xb5;l water. 700 &#xb5;l absolute ethanol was added to a final concentration of 70% (v/v) and vortexes. Cells were spun down at 8500x<italic>g</italic> for 5&#xa0;min, the supernatant completely discarded and the cells lysed first with 50 &#xb5;l 70% (v/v) formic acid, and 50 &#xb5;l pure acetonitrile. Modifications to this protocol tested were for preprocessing protocol (B) that cells were collected in 300 &#xb5;l 5% (v/v) DMSO<sub>ad</sub>, for preprocessing protocol (C) that DMSO was included in the 70% ethanol washing step to a final volume of 5% (v/v), and for preprocessing protocol (D) that cells were collected in 300 &#xb5;l water already including an equivalent of ~100 &#xb5;l glass beads (0.5&#xa0;mm diameter, Roth, Karlsruhe, Germany). Here, cells were mechanically disrupted in a FP120 fast prep machine (Bio101, Thermo Savant) at setting 4, for 30 sec during the formic acid step.</p>
</sec>
<sec id="s2_4">
<title>Generation of MALDI Biotyper Database References</title>
<p>MSP references for the MALDI Biotyper were generated according to the manufacturer&#x2019;s guidelines (<xref ref-type="bibr" rid="B13">Kostrzewa and Maier, 2017</xref>), using preprocessing protocol A. Spectra from 24 individual spots were gathered on a freshly calibrated (BTS reference standard) Autoflex III system (Bruker Daltonics, Bremen, Germany) using the automated acquisition mode of the Biotyper 3.1. Spectra were processed using the inbuilt MSP generation method, using the standard parameters.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results and Discussion</title>
<sec id="s3_1">
<title>Method Optimization</title>
<p>The literature reports that both, removal of cryptococcal capsule can (<xref ref-type="bibr" rid="B23">Thomaz et&#xa0;al., 2016</xref>) or does not (<xref ref-type="bibr" rid="B8">Hagen et&#xa0;al., 2015</xref>) positively influence spectrum quality. Since the capsule material is soluble in DMSO, we devised pre-processing protocols that would deplete the capsule prior to the regular formic acid/acetonitrile extraction protocol. Both pre-processing protocols, B (<xref ref-type="fig" rid="f1">
<bold>Figures 1A, B</bold>
</xref>) and C (not shown), efficiently removed capsules in all strains. However, subsequent measurement of mass spectra did not reveal any additional mass signals, or major differences in spectrum quality (<xref ref-type="fig" rid="f1">
<bold>Figure 1C</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure 1</label>
<caption>
<p>Optimization of sample pre-processing procedures. Phase contrast microscopy of ink-stained cryptococcal cells <bold>(A)</bold> without and <bold>(B)</bold> with DMSO treatment depleting capsular material (protocol B). <bold>(C)</bold> Spectra obtained from de-capsulated cells by protocols B and C were not different from those generated by formic acid extraction alone. <bold>(D)</bold> Spectra obtained from mechanically disrupted cells (protocol D) had similar masses, but differed in relative signal intensity for some, as compared to those obtained by formic acid extraction. Example results shown here for CBS 10485 are valid for all isolates. Signal intensities on y-axes in panels <bold>(C, D)</bold> mainly rely on number of spectra gathered in sum buffer. Spectra have been manually re-scaled on the y-axis for better visual comparison between different experimental conditions, and scaling has been omitted to reflect this fact.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-634382-g001.tif"/>
</fig>
<p>Next, we tested if mechanical disruption of the cells yielded more informative spectra using mechanical disruption (preprocessing protocol D). Indeed, mass spectra recorded from mechanically disrupted cells resulted in more evenly distributed peak intensities across the major mass signals. However, no additional mass signals of high intensity were found (<xref ref-type="fig" rid="f1">
<bold>Figure 1D</bold>
</xref>).</p>
<p>In our hands removal of the capsule did not result in spectra with higher information content, at any time. Mechanical disruption did reveal some additional masses, but in favor of the lower hands-on-time the original pre-processing protocol A was subsequently used for MSP creation and testing.</p>
</sec>
<sec id="s3_2">
<title>Creation of Single Species MSPs</title>
<p>Next, we created MSPs for 13 reference strains encompassing seven molecular types of the <italic>C. neoformans/gattii</italic> complexes (<xref ref-type="bibr" rid="B18">Meyer et&#xa0;al., 2003</xref>; <xref ref-type="bibr" rid="B8">Hagen et&#xa0;al., 2015</xref>), using the standard extraction procedure (pre-processing protocol A). Cluster analysis of the MSPs generated suggested sufficient distance to clearly distinguish between <italic>C. neoformans</italic> complex molecular types VNIV (<italic>C. deneoformans</italic>) and VNI/II, and possibly also between VNI and VNII themselves, but less so among molecular types within the <italic>C. gattii</italic> complex (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure 2</label>
<caption>
<p>Dendrogram reference MSPs.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-634382-g002.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>Identification Performance</title>
<p>Mass spectra for all test isolates were obtained using preprocessing protocol A. Were MALDI-TOF results using the new MSP set deviated from previous data, <italic>URA5</italic>-RFLP typing was repeated as the gold standard (<xref ref-type="fig" rid="f3">
<bold>Figure 3A</bold>
</xref>). All but two deviations could be resolved (see below). To discriminate between <italic>C. tetragattii</italic> and potential <italic>C. decagattii</italic> strains, we sequenced the <italic>URA5</italic>-amplicon obtained from CBS 11687 (<italic>C. decagattii</italic>, deposited at Genebank under the accession number MH605184) and compared it to the respective sequence of CBS 10101 (<italic>C. tetragattii</italic>, gene bank accession AY973155). Restriction with StuI was found, and experimentally confirmed, to discriminate the two species (<xref ref-type="fig" rid="f3">
<bold>Figure 3B</bold>
</xref>). However, there were no further <italic>C. decagattii</italic> isolates among our strains. <italic>C. decagattii</italic> remains a rare species, and only a single isolate of this molecular type (CBS 11687) was available for this study, which was already included in the reference set. Therefore, the final test collection encompassed only six of the seven species used for generation of references.</p>
<fig id="f3" position="float">
<label>Figure 3</label>
<caption>
<p>
<italic>URA5</italic>-RFLPs. <bold>(A)</bold> <italic>URA5</italic>-RFLP patterns of control isolates. <bold>(B)</bold> CBS10101 (<italic>C. tetragattii</italic>) and CBS 11687 (<italic>C. decagattii</italic>) can be differentiated by digesting the <italic>URA5</italic>-amplicon with StuI. <bold>(C)</bold> log-score values stratified by species/<italic>URA5</italic>-RFLP and matching type. Green: scores of correct matches, red: highest scoring incorrect matches. <bold>(D)</bold> Pairwise percentages of highest scoring <italic>in</italic>correct matches. <sup>a</sup> <italic>C</italic>. <italic>decagattii</italic> was not present among testing isolates, as the only strain available for this study was already used to create the MSP reference.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-634382-g003.tif"/>
</fig>
<p>From the test collection, we were able to correctly identify 143/153 (93.5%) of the isolates on species-level using duplicate spots, with the top log score &#x2265; 2.000 (<xref ref-type="fig" rid="f3">
<bold>Figure 3C</bold>
</xref>), as recommended by the manufacturer. Of the remaining ten isolates, eight still gave correct species matches at scores between 1.700 and 1.999, considered only genus-level by the manufacturer. Among the negative control set, there were no results higher than a log score of 1.300, indicating no false positives are to be expected under routine diagnostic conditions (<xref ref-type="fig" rid="f3">
<bold>Figure 3C</bold>
</xref>). Inconsistent identifications were only observed for two <italic>C. tetragattii</italic> isolates where repetitively top matches of different spots of the same preparation were <italic>C. tetragattii, C. gattii</italic>, or <italic>C. deuterogattii</italic>, all at values above 1.999.</p>
<p>Because of this, and the close relations found during cluster analysis (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>), we also inspected the log score difference from the correct to the highest scoring false match for each spot (<xref ref-type="fig" rid="f3">
<bold>Figure 3D</bold>
</xref>) for those tests where a second species matched above the significance threshold. Only 3% of all tested spots (14 out of 428) matched a second MSP with a log score &gt;1.999. As expected from the cluster analysis, these &#x201c;best false&#x201d; second matches were found only among species in the <italic>C. gattii</italic> complex. This was the case for three <italic>C. bacillisporus</italic> isolates giving a second best match with <italic>C. decagattii</italic>, with a log score difference between 0.1 to 0.4. In addition to the two inconsistent <italic>C. tetragattii</italic> isolates discussed above, one additional <italic>C. tetragattii</italic> isolate also gave a second best match with <italic>C. decagattii</italic>. The score values for both matches were near 2.000. The close relationships of the different species will likely also have implications on properly identifying hybrid isolates.</p>
</sec>
</sec>
<sec id="s4">
<title>Conclusion</title>
<p>Cryptococcal typing and species identification is complicated by the ongoing discovery of new species (<xref ref-type="bibr" rid="B6">Farrer et&#xa0;al., 2019</xref>), and the formation of inter-species hybrids (<xref ref-type="bibr" rid="B8">Hagen et&#xa0;al., 2015</xref>). Nevertheless, our data confirms that proper routine identification of clinically relevant non-hybrid <italic>C. neoformans/gattii</italic> complex molecular types using MALDI-TOF is possible with the current algorithms and standard workflows. In our hands, the only exception was distinguishing the rarer types <italic>C. tetragattii</italic> and <italic>C.&#xa0;decagattii</italic>, which was not sufficiently possible. This may be due to the fact, that only low numbers of isolates of these linages were available for testing.</p>
<p>The MSP sets generated in this study are freely available from <uri xlink:href="https://github.com/oliverbader/BioTyper-libraries">https://github.com/oliverbader/BioTyper-libraries</uri> for use with the molecular type- (<xref ref-type="bibr" rid="B18">Meyer et&#xa0;al., 2003</xref>) or the species nomenclatures (<xref ref-type="bibr" rid="B8">Hagen et&#xa0;al., 2015</xref>).</p>
</sec>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>Performed experiments: MB, NW, MK, OB. Contributed typed strains: NW, MK, CB, WT, AC. Wrote the manuscript: MB, AC, OB. Prepared the revision: MB, OB. Supervised the study: MW, UG, AC, OB. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>This study received funding from Thai-German mobility scheme &#x201c;CryptoType&#x201d; to AC and OB (grant number 01DP13001). Article publishing fees were covered by the Open-Access-publications funds of the Universit&#xe4;tsmedizin G&#xf6;ttingen.</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors would like to thank Agnieszka Goretzki for expert technical assistance. This study was mainly funded by the Thai-German mobility scheme &#x201c;CryptoType&#x201d; to AC and OB.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bader</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Fungal Species Identification by MALDI-ToF Mass Spectrometry</article-title>. <source>Methods Mol. Biol.</source> <volume>1508</volume>, <fpage>323</fpage>&#x2013;<lpage>337</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-1-4939-6515-1_19</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boekhout</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Theelen</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Diaz</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Fell</surname> <given-names>J. W.</given-names>
</name>
<name>
<surname>Hop</surname> <given-names>W. C.</given-names>
</name>
<name>
<surname>Abeln</surname> <given-names>E. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2001</year>). <article-title>Hybrid genotypes in the pathogenic yeast <italic>Cryptococcus neoformans</italic>
</article-title>. <source>Microbiology</source> <volume>147</volume>, <fpage>891</fpage>&#x2013;<lpage>907</lpage>. doi: <pub-id pub-id-type="doi">10.1099/00221287-147-4-891</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carriconde</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Gilgado</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Arthur</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Ellis</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Malik</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Van De Wiele</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Clonality and alpha-a recombination in the Australian <italic>Cryptococcus gattii</italic> VGII population&#x2013;an emerging outbreak in Australia</article-title>. <source>PloS One</source> <volume>6</volume>, <fpage>e16936</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0016936</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cogliati</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Prigitano</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Esposto</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Romano</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Grancini</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Zani</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Epidemiological trends of cryptococcosis in Italy: Molecular typing and susceptibility pattern of <italic>Cryptococcus neoformans</italic> isolates collected during a 20-year period</article-title>. <source>Med. Mycol.</source> <volume>56</volume>, <fpage>963</fpage>&#x2013;<lpage>971</lpage>. doi: <pub-id pub-id-type="doi">10.1093/mmy/myx152</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname> <given-names>L. F.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>P. P.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>T. T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017</article-title>. <source>Braz. J. Infect. Dis.</source> <volume>24</volume>, <fpage>7</fpage>&#x2013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bjid.2019.11.004</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farrer</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Van Dorp</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>D. H.</given-names>
</name>
<name>
<surname>Shea</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>A New Lineage of Cryptococcus gattii (VGV) Discovered in the Central Zambezian Miombo Woodlands</article-title>. <source>mBio</source> <volume>10</volume> (<issue>6</issue>), <fpage>e02306-19</fpage>. doi: <pub-id pub-id-type="doi">10.1128/mBio.02306-19</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Firacative</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Trilles</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Meyer</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>MALDI-TOF MS enables the rapid identification of the major molecular types within the <italic>Cryptococcus neoformans</italic>/<italic>C. gattii</italic> species complex</article-title>. <source>PloS One</source> <volume>7</volume>, <fpage>e37566</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0037566 </pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagen</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Khayhan</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Theelen</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Kolecka</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Polacheck</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Sionov</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Recognition of seven species in the <italic>Cryptococcus gattii</italic>/<italic>Cryptococcus neoformans</italic> species complex</article-title>. <source>Fungal Genet. Biol.</source> <volume>78</volume>, <fpage>16</fpage>&#x2013;<lpage>48</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.fgb.2015.02.009</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herkert</surname> <given-names>P. F.</given-names>
</name>
<name>
<surname>Dos Santos</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Hagen</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Ribeiro-Dias</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Queiroz-Telles</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Netea</surname> <given-names>M. G.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Differential In Vitro Cytokine Induction by the Species of <italic>Cryptococcus gattii</italic> Complex</article-title>. <source>Infect. Immun.</source> <volume>86</volume> (<issue>4</issue>), <fpage>e00958-17</fpage>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00958-17</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>X. Y.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L. F.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Clinical and microbiological characteristics of Cryptococcus gattii isolated from 7 hospitals in China</article-title>. <source>BMC Microbiol.</source> <volume>20</volume>, <fpage>73</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12866-020-01752-4</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kangogo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bader</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Boga</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wanyoike</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Folba</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Worasilchai</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Molecular types of <italic>Cryptococcus gattii</italic>/<italic>Cryptococcus neoformans</italic> species complex from clinical and environmental sources in Nairobi, Kenya</article-title>. <source>Mycoses</source> <volume>58</volume>, <fpage>665</fpage>&#x2013;<lpage>670</lpage>. doi: <pub-id pub-id-type="doi">10.1111/myc.12411</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kidd</surname> <given-names>S. E.</given-names>
</name>
<name>
<surname>Hagen</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Tscharke</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Huynh</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bartlett</surname> <given-names>K. H.</given-names>
</name>
<name>
<surname>Fyfe</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>A rare genotype of <italic>Cryptococcus gattii</italic> caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>101</volume>, <fpage>17258</fpage>&#x2013;<lpage>17263</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0402981101</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Kostrzewa</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Maier</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2017</year>). &#x201c;<article-title>Criteria for Development of MALDI-TOF Mass Spectral Database</article-title>,&#x201d; in <source>MALDI-TOF and Tandem MS for Clinical Microbiology</source>, <edition>one ed.</edition> Eds. <person-group person-group-type="editor">
<name>
<surname>Shah</surname> <given-names>H. N.</given-names>
</name>
<name>
<surname>Garbia</surname> <given-names>S. E.</given-names>
</name>
</person-group> (<publisher-loc>Hoboken, New Jersey</publisher-loc>: <publisher-name>John Wiley &amp; Sons Ltd</publisher-name>), <fpage>39</fpage>&#x2013;<lpage>54</lpage>.</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kronstad</surname> <given-names>J. W.</given-names>
</name>
<name>
<surname>Attarian</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Cadieux</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>J.</given-names>
</name>
<name>
<surname>D&#x2019;souza</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Griffiths</surname> <given-names>E. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Expanding fungal pathogenesis: <italic>Cryptococcus</italic> breaks out of the opportunistic box</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>9</volume>, <fpage>193</fpage>&#x2013;<lpage>203</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro2522</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon-Chung</surname> <given-names>K. L.</given-names>
</name>
<name>
<surname>Boekhout</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Fell</surname> <given-names>J. W.</given-names>
</name>
<name>
<surname>Diaz</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Proposal to conserve the name <italic>Cryptococcus gattii</italic> against <italic>C. hondurianus</italic> and <italic>C. bacillisporus</italic> (Basidiomycota, Hymenomycetes, Tremenomycetidae)</article-title>. <source>Taxon</source> <volume>51</volume>, <fpage>804</fpage>&#x2013;<lpage>806</lpage>. doi: <pub-id pub-id-type="doi">10.2307/1555045</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>G. A.</given-names>
</name>
<name>
<surname>Arthur</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Merritt</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Leung</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Molecular types of <italic>Cryptococcus neoformans</italic> and <italic>Cryptococcus gattii in</italic> Western Australia and correlation with antifungal susceptibility</article-title>. <source>Med. Mycol</source>. <volume>57</volume> (<issue>8</issue>), <fpage>1004</fpage>&#x2013;<lpage>1010</lpage>. doi: <pub-id pub-id-type="doi">10.1093/mmy/myy161</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McTaggart</surname> <given-names>L. R.</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Richardson</surname> <given-names>S. E.</given-names>
</name>
<name>
<surname>Hoang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Fothergill</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S. X.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Rapid identification of <italic>Cryptococcus neoformans</italic> and <italic>Cryptococcus gattii</italic> by matrix-assisted laser desorption ionization-time of flight mass spectrometry</article-title>. <source>J. Clin. Microbiol.</source> <volume>49</volume>, <fpage>3050</fpage>&#x2013;<lpage>3053</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JCM.00651-11</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Castaneda</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Jackson</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Huynh</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Castaneda</surname> <given-names>E.</given-names>
</name>
<collab>Iberoamerican Cryptococcal Study Group</collab>
</person-group> (<year>2003</year>). <article-title>Molecular typing of IberoAmerican <italic>Cryptococcus neoformans</italic> isolates</article-title>. <source>Emerg. Infect. Dis.</source> <volume>9</volume>, <fpage>189</fpage>&#x2013;<lpage>195</lpage>. doi: <pub-id pub-id-type="doi">10.3201/eid0902.020246</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Meara</surname> <given-names>T. R.</given-names>
</name>
<name>
<surname>Alspaugh</surname> <given-names>J. A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The <italic>Cryptococcus neoformans</italic> capsule: a sword and a shield</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>25</volume>, <fpage>387</fpage>&#x2013;<lpage>408</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CMR.00001-12</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Posteraro</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Vella</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Cogliati</surname> <given-names>M.</given-names>
</name>
<name>
<surname>De Carolis</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Florio</surname> <given-names>A. R.</given-names>
</name>
<name>
<surname>Posteraro</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Method for Discrimination between Molecular Types of <italic>Cryptococcus neoformans</italic> and <italic>Cryptococcus gattii</italic>
</article-title>. <source>J. Clin. Microbiol.</source> <volume>50</volume>, <fpage>2472</fpage>&#x2013;<lpage>2476</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JCM.00737-12</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Springer</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Billmyre</surname> <given-names>R. B.</given-names>
</name>
<name>
<surname>Filler</surname> <given-names>E. E.</given-names>
</name>
<name>
<surname>Voelz</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Pursall</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Mieczkowski</surname> <given-names>P. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>
<italic>Cryptococcus gattii</italic> VGIII isolates causing infections in HIV/AIDS patients in Southern California: identification of the local environmental source as arboreal</article-title>. <source>PloS Pathog.</source> <volume>10</volume>, <fpage>e1004285</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1004285</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tangwattanachuleeporn</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Somparn</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Poolpol</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Gross</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Weig</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bader</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Prevalence and Antifungal Susceptibility of <italic>Cryptococcus neoformans</italic> Isolated from Pigeon Excreta in Chon Buri Province, Eastern Thailand</article-title>. <source>Med. Mycol. J.</source> <volume>54</volume>, <fpage>303</fpage>&#x2013;<lpage>307</lpage>. doi: <pub-id pub-id-type="doi">10.3314/mmj.54.303</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomaz</surname> <given-names>D. Y.</given-names>
</name>
<name>
<surname>Grenfell</surname> <given-names>R. C.</given-names>
</name>
<name>
<surname>Vidal</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Giudice</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Del Negro</surname> <given-names>G. M.</given-names>
</name>
<name>
<surname>Juliano</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Does the Capsule Interfere with Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of <italic>Cryptococcus neoformans</italic> and <italic>Cryptococcus gattii</italic>
</article-title>? <source>J. Clin. Microbiol.</source> <volume>54</volume>, <fpage>474</fpage>&#x2013;<lpage>477</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JCM.02635-15</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trilles</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Meyer</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Wanke</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Guarro</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lazera</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Correlation of antifungal susceptibility and molecular type within the <italic>Cryptococcus neoformans</italic>/<italic>C. gattii</italic> species complex</article-title>. <source>Med. Mycol.</source> <volume>50</volume>, <fpage>328</fpage>&#x2013;<lpage>332</lpage>. doi: <pub-id pub-id-type="doi">10.3109/13693786.2011.602126</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voelz</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Johnston</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Hall</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Idnurm</surname> <given-names>A.</given-names>
</name>
<name>
<surname>May</surname> <given-names>R. C.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>&#x2018;Division of labour&#x2019; in response to host oxidative burst drives a fatal <italic>Cryptococcus gattii</italic> outbreak</article-title>. <source>Nat. Commun.</source> <volume>5</volume>, <fpage>5194</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ncomms6194</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Worasilchai</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Tangwattanachuleeporn</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Meesilpavikkai</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Folba</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Kangogo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gross</surname> <given-names>U.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Diversity and Antifungal Drug Susceptibility of <italic>Cryptococcus</italic> Isolates in Thailand</article-title>. <source>Med. Mycol.</source> <volume>55</volume>, <fpage>680</fpage>&#x2013;<lpage>685</lpage>. doi: <pub-id pub-id-type="doi">10.1093/mmy/myw130.</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>